Combined Surgery Offers Hope for Severely Obese Liver Transplant Patients

Research & Discovery > Combined Surgery Offers Hope for Severely Obese Liver Transplant Patients

Combined Surgery Offers Hope for Severely Obese Liver Transplant Patients

By Mayo Clinic Illustration by Jacey Tec

Share

Share this:

A groundbreaking Mayo Clinic study has found that combining bariatric surgery with liver transplantation provides significant long-term health benefits for patients with severe obesity who traditionally face transplant denial due to their weight.

The research conducted over 10 years compared patients who received liver transplants alone versus those who underwent both procedures simultaneously. The combined approach produced sustained weight loss, reduced risk of type 2 diabetes, and decreased fatty liver disease recurrence without additional surgical risks.

This dual approach is aimed at addressing long-term obesity complications like diabetes, heart disease and cancer, while also preventing fatty liver disease recurrence.

— Julie Heimbach, M.D.

This innovation addresses a growing challenge: More than 41% of liver transplant candidates are obese, with a body mass index (BMI) above 30. Patients with BMI of 40 or greater face frequent transplant denial, creating a critical treatment gap.

“We’ve been amazed by the transformation our patients experience,” says Julie Heimbach, M.D., director of Mayo Clinic Transplant Center and the study’s senior author. “This dual approach is aimed at addressing long-term obesity complications like diabetes, heart disease and cancer, while also preventing fatty liver disease recurrence.”

The multidisciplinary approach protects the transplanted liver from the same metabolic dysfunction that caused the original liver failure. Bariatric surgery remains an effective option for patients with severe obesity due to its proven effectiveness and lasting results.

This breakthrough expands treatment options for vulnerable patients facing life-threatening liver disease.